Stuttgart - Delayed Quote EUR
Intellia Therapeutics Inc (38I.SG)
8.01
+1.11
+(16.05%)
At close: May 2 at 9:26:28 PM GMT+2
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 38I.SG | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Upgrade | Wolfe Research: Peer Perform to Outperform | 4/21/2025 |
| Initiated | HC Wainwright & Co.: Buy | 3/5/2025 |
| Maintains | Truist Securities: Buy to Buy | 3/4/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/28/2025 |
| Maintains | Citigroup: Neutral to Neutral | 2/28/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
Related Tickers
VLA.VI Valneva SE
2.9320
+4.86%
BT3.BE Lineage Cell Therapeutics Inc
0.4320
+7.46%
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
328.SG MeiraGTx Holdings PLC
6.45
+4.03%
25I.SG ImmuPharma PLC
0.0325
-1.52%
8QQ.HM AbCellera Biologics Inc
2.1850
-1.93%
HQ1.MU Oruka Therapeutics Inc. R
9.10
0.00%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
PI3.DU Gubra AS
54.00
+9.27%
2I3.F Champions Oncology, Inc.
5.15
-19.53%